IQE (IQE) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
13 Jun, 2025Trading performance
Revenue for H1 2024 expected to be at least £65m, a year-on-year increase of at least 25% and a 3% rise from H2 2023.
Trading remains in line with management expectations, reflecting ongoing recovery in the industry.
Strategic outlook
Continued revenue growth supports strategic progress and confidence in the diversification strategy.
The company is positioned to capitalize on growth opportunities as markets recover at different rates.
Company positioning
IQE is a leading global supplier of compound semiconductor wafers and advanced material solutions.
The group leverages its intellectual property to deliver high-quality, cost-effective epitaxy wafers for diverse applications.
Operations span eight manufacturing locations in the UK, US, and Taiwan, serving global markets.
Latest events from IQE
- Board changes, GenAI-driven strategy, and technology innovation highlighted amid industry recovery.IQE
AGM 20243 Feb 2026 - 27% revenue growth and positive EBITDA, led by Wireless gains and Taiwan IPO plans.IQE
H1 202421 Jan 2026 - Revenue and order book strength position the group for growth as strategic review advances.IQE
Trading Update12 Jan 2026 - Adjusted EBITDA nearly doubled on flat revenue; strategic review targets debt-free growth.IQE
H2 202426 Nov 2025 - Revenue fell 31% year-over-year to £45.3m, with deepening losses and a potential full sale.IQE
H1 202520 Oct 2025 - IQE launches a strategic review and seeks £15m financing as 2024 revenue remains flat.IQE
Trading Update13 Jun 2025 - FY24 revenue and EBITDA to surpass expectations; strategic review and financing progressing.IQE
Trading Update6 Jun 2025